Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Kaempferol helps skin stem cells grow and may improve skin thickness due to its 3-OH group.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Certain Chinese herbs may help treat kidney fibrosis by targeting TGF-β.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

Bee pollen, green tea, essential oils, and various plant extracts improve skin and hair health.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Leflunomide is more likely to help treat alopecia areata than cause it.

Cancer treatments often cause skin, nail, and hair problems.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Upadacitinib may effectively treat alopecia areata without side effects.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Upadacitinib improved multiple immune-related conditions in one patient.